Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
about
Early detection of diabetic kidney disease: Present limitations and future perspectivesUrinary Markers of Tubular Injury in Early Diabetic NephropathyClinical Predictive Factors in Diabetic Kidney Disease ProgressionBiomarkers of Renal Disease and Progression in Patients with DiabetesMolecular mechanisms of diabetic kidney diseaseTherapeutic modalities in diabetic nephropathy: standard and emerging approaches.Biomarkers in chronic kidney disease, from kidney function to kidney damageFibrinogen β-derived Bβ(15-42) peptide protects against kidney ischemia/reperfusion injuryDiabetic Nephropathy: New Risk Factors and Improvements in DiagnosisRenal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytesUremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic studyKidney injury molecule-1: a translational journey.Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men.Biomarkers for early detection of sickle nephropathyAssociation of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitusThe proximal tubule in the pathophysiology of the diabetic kidney.Normalisation of urinary biomarkers to creatinine for clinical practice and research--when and why.Urinary biomarker N-acetyl-β-D-glucosaminidase can predict severity of renal damage in diabetic nephropathy.Kidney injury molecule-1 as a predicting factor for inflamed kidney, diabetic and diabetic nephropathy Egyptian patientsProximal tubule dysfunction is associated with podocyte damage biomarkers nephrin and vascular endothelial growth factor in type 2 diabetes mellitus patients: a cross-sectional study.Hyperglycemia and renin-dependent hypertension synergize to model diabetic nephropathy.Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney diseaseIL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease.Meclizine Preconditioning Protects the Kidney Against Ischemia-Reperfusion Injury.Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.Association between Urinary N-Acetyl-Beta-D-Glucosaminidase and Microalbuminuria in Diabetic Black Africans.Early Markers of Tubulointerstitial Fibrosis in Children With Idiopathic Nephrotic Syndrome: Preliminary Report.Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosisUrinary cystatin C and tubular proteinuria predict progression of diabetic nephropathyAquaporin 11 variant associates with kidney disease in type 2 diabetic patients.Can we target tubular damage to prevent renal function decline in diabetes?Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.Levels of albuminuria and risk of developing macroalbuminuria in type 2 diabetes: historical cohort studySerum cystatin C and tubular urinary enzymes as biomarkers of renal dysfunction in type 2 diabetes mellitusAssociations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes.Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers.A bioinformatics approach identifies signal transducer and activator of transcription-3 and checkpoint kinase 1 as upstream regulators of kidney injury molecule-1 after kidney injury.Chemokine profile in the sera and urine of patients with schistosomal glomerulopathy.Netrin-1, a urinary proximal tubular injury marker, is elevated early in the time course of human diabetes.
P2860
Q26741494-D0A1EA4B-1026-4877-A90A-5A6FFEE34647Q26746921-A0B5E1B4-87AA-472E-89C3-725B2D34AA4BQ26749494-B3529C14-881B-4C93-85FE-BE33D727E3B9Q26799505-91FB49A9-4291-4228-9F72-BD798C99B063Q27003963-12143C4F-76D3-46D4-8AB9-F7910A56BBEAQ27007027-69D35F7D-6835-4C85-A1E1-8DE06292B573Q28087304-B6A4D360-F764-4075-9D6E-1029D6584F6EQ28573774-2B11D659-A9EC-4AD0-9246-8E165D5DF2A7Q33583018-2B63C4FE-393D-40F9-84CA-419F06FC9332Q33697388-A89A6003-2B16-4ACB-8F79-22934A85B1A8Q33810793-F72743FB-62FB-448C-A4A4-34D118A10707Q33957747-1DC7B050-ADF5-47FD-A722-BC19E1111A51Q34008962-11BCCD90-4945-4A2D-AE1D-A3BBB59F92D5Q34204444-5412A86C-AA22-4EDB-9D8D-F9550D97214AQ34644160-D00F3A4E-F667-4798-BAE6-BAE244E0FCDFQ34979592-EA0BB5B8-1CB6-4E58-B46D-ADE23D44F14FQ35076289-552868ED-4395-4C7F-A895-F38F6E37342AQ35120380-3D36478F-35F8-4BF8-9F5A-7C9B0633508CQ35141979-602FDEBB-F95F-498B-8562-516913C6A335Q35421414-45160675-4294-4B36-85FE-8BEA5D45B346Q35804146-8DABD2A7-F419-4D36-899A-5E4ECB7AE786Q35898342-3D6E71C3-6073-4000-8BE7-933DD45BC6E7Q36040523-064952FB-D517-4E70-B31A-883F3D067624Q36106304-B4103ED5-6920-478E-922D-C14DC497698AQ36200281-BA5F55D2-284B-4A05-99C8-DE899C133904Q36206558-E5C18225-BCF5-4EE4-82DC-087BF0845AF4Q36207035-5DE8DC4D-3E48-4E67-A505-DC1B55F73EEDQ36344904-4E223E27-0395-47E7-93F3-A9B541B4B935Q36629471-BCC7A9EB-F439-48F4-8C4E-68F350A32DE7Q36638411-CDC1AE17-F9DF-4B5C-8766-01047086AD3AQ36677752-DE33BBF8-68E7-4A68-A624-646C4661E765Q36770851-B42ACCF1-D3C5-424C-9671-2B249BC70F65Q36844894-2BD848D4-4103-494D-A225-5F07F48F831CQ36925586-439173B7-68FD-430E-9E36-F9210093DE40Q37082626-C8EF75FC-DC53-4F05-B5A0-29ED3D9F0381Q37139796-8C5F7FE9-9FC6-4D08-B42A-8C004F64010AQ37142447-E4EBD715-6BB9-49F0-BEEE-6608BF50B366Q37411647-70568BA4-454A-4B0F-9D0B-70C28A340F2DQ37456159-8CE8261A-968D-43A0-A93F-232C83C2A10FQ37662146-DE2E19CA-5333-499A-A249-5A3BDE844BA6
P2860
Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@ast
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@en
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@nl
type
label
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@ast
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@en
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@nl
prefLabel
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@ast
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@en
Regression of microalbuminuria ...... N-acetyl-β-D-glucosaminidase.
@nl
P2093
P2860
P356
P1433
P1476
Regression of microalbuminuria ...... d N-acetyl-β-D-glucosaminidase
@en
P2093
Amanda C Johnson
Andrzej S Krolewski
Fitz B Collings
James H Warram
Joseph V Bonventre
Monika A Niewczas
Vishal S Vaidya
P2860
P2888
P304
P356
10.1038/KI.2010.404
P407
P577
2010-10-27T00:00:00Z
P5875
P6179
1031638176